| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/20/2009 | CN101437813A Mglur5 modulators III |
| 05/20/2009 | CN101437812A Quinoline derivatives for treating cancer |
| 05/20/2009 | CN101437811A Quinoline derivatives |
| 05/20/2009 | CN101437810A Quinazoline derivatives |
| 05/20/2009 | CN101437803A Dibenzyl amine derivatives as CETP inhibitors |
| 05/20/2009 | CN101437800A Compounds and compositions as HEDGEHOG pathway modulators |
| 05/20/2009 | CN101437798A Mglur5 modulators II |
| 05/20/2009 | CN101437398A Cannabinoid receptor antagonists/inverse agonists useful fortreating obesity |
| 05/20/2009 | CN101434600A Curcumin piperidone analog and use thereof in anti-tumor medicament |
| 05/20/2009 | CN101434599A Mixed metal complex emitting white light and preparation thereof |
| 05/20/2009 | CN101434598A Preparation of cilostazol |
| 05/20/2009 | CN101434597A Method for recycling imidacloprid from imidacloprid production mother liquor |
| 05/20/2009 | CN101434596A Novel azaheterocyclic amides useful for treating pain |
| 05/20/2009 | CN100488969C Optically active substituted oxyphosphonate salt acetate and its use |
| 05/20/2009 | CN100488961C Argatroban byproduct and its synthesis, separation and identification method |
| 05/20/2009 | CN100488960C 2-substituted quinolone compound and use in pharmacy |
| 05/20/2009 | CN100488959C Water soluble thalidomide derivative |
| 05/20/2009 | CN100488958C 3-substituted-4-pyrimidone derivatives |
| 05/20/2009 | CN100488952C 5-phenyl pyridine, its preparation method and intermediate product and uses in controlling harmful fungus |
| 05/20/2009 | CN100488948C N-substituted indole-3-acetaldehyde amide compound with anti-asthma, anti-amaphylactic and immunosupression/immunoregulation action |
| 05/20/2009 | CN100488512C Compositions for treatment of cell proliferative disorders and its uses |
| 05/20/2009 | CN100488362C Herbicidal composition |
| 05/19/2009 | US7534915 Non-symmetrical gelling agent |
| 05/19/2009 | US7534897 Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism |
| 05/19/2009 | US7534893 Imidazol-2-one compounds useful in the treatment of various disorders |
| 05/19/2009 | US7534892 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent |
| 05/19/2009 | US7534884 Preparation of pharmaceutical salts |
| 05/19/2009 | US7534808 Indolylmaleimide derivatives |
| 05/19/2009 | US7534805 Imidazole derivatives, their preparation and their use as medicaments |
| 05/19/2009 | US7534803 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 05/19/2009 | US7534802 Compounds having 4-pyridylalkylthio group as substituent |
| 05/19/2009 | US7534801 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 05/19/2009 | US7534798 Vanilloid receptor ligands and their use in treatments |
| 05/19/2009 | US7534796 Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| 05/19/2009 | US7534794 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| 05/19/2009 | US7534793 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 05/19/2009 | US7534784 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 05/19/2009 | US7534777 Des-C,D analogs of 1α,25-dihydroxy-19-norvitamin D3 |
| 05/19/2009 | CA2498047C Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 05/19/2009 | CA2368059C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 05/19/2009 | CA2364801C Pyridazin-3-one derivatives and medicines containing the same |
| 05/19/2009 | CA2336634C Antiviral macrocyclic compounds |
| 05/19/2009 | CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/19/2009 | CA2211381C Compounds with growth hormone releasing properties |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/14/2009 | WO2009061875A2 Processes and intermediates for producing aminobenzimidazole ureas |
| 05/14/2009 | WO2009061761A2 Fungicidal heterocyclic amines |
| 05/14/2009 | WO2009061652A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | WO2009061597A1 Compounds for inhibiting ksp kinesin activity |
| 05/14/2009 | WO2009061498A1 CYCLIC UREA INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| 05/14/2009 | WO2009061271A1 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/14/2009 | WO2009060742A1 Organic electroluminescent device, display device, and illuminating device |
| 05/14/2009 | WO2009060463A1 An environmentally friendly process for the preparation of imatinib base |
| 05/14/2009 | WO2009060209A1 6,6-fused bicyclic aromatic compounds and their therapeuti use |
| 05/14/2009 | WO2009060174A1 Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides |
| 05/14/2009 | WO2009060114A1 Inhibitors of enzyme o6-alkylguanine-dna-methyltransferase for cancer treatment |
| 05/14/2009 | WO2009060054A1 Triazole derivatives as scd inhibitors |
| 05/14/2009 | WO2009060030A1 Heteroaryl-substituted 2-pyridinylmethylamine derivatives |
| 05/14/2009 | WO2009059943A1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 05/14/2009 | WO2009041789A3 Novel 3-chloro-5-substituted-quinoxaline-2-amine derivatives and pharmaceutically acceptable salt thereof, method for preparation, therapeutic agent for inflammatory disease induced by spc activity containing 3-chloro-5-substituted-quinoxaline-2-amine derivatives as an effective ingredient |
| 05/14/2009 | WO2009031040A3 Compounds with anti-cancer activity |
| 05/14/2009 | WO2009027601A3 Pyrazole 3,5 carboxylate derivatives preparation and therapeutic application thereof |
| 05/14/2009 | WO2008118823A3 Compositions and methods for inhibition of the jak pathway |
| 05/14/2009 | WO2008060626A3 Compounds for modulating trpv3 function |
| 05/14/2009 | WO2008049123A8 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 05/14/2009 | US20090124811 Method for resolving omeprazole salts |
| 05/14/2009 | US20090124804 Enantioselective process for preparing a substituted alkanoic acid |
| 05/14/2009 | US20090124668 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/14/2009 | US20090124665 Potassium Channel Inhibitors |
| 05/14/2009 | US20090124646 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 05/14/2009 | US20090124636 Chemical compounds |
| 05/14/2009 | US20090124635 Chemical compounds |
| 05/14/2009 | US20090124633 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases |
| 05/14/2009 | US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors |
| 05/14/2009 | US20090124621 Pyrazole derivatives as kinase inhibitors |
| 05/14/2009 | US20090124617 Quinolone derivative or salt thereof |
| 05/14/2009 | US20090124616 7-nonsubstituted indole mcl-1 inhibitors |
| 05/14/2009 | US20090124615 3-[((1R)-1-{2-Chloro-3-[(1-methyl-4-piperidinyl)oxy]phenyl}ethyl)oxy]-5-[5-(1-methyl-1H-pyrazol-4-yl)-1H-benzimidazol-1-yl]-2-thiophenecarboxamide; polo like kinase enzyme inhibitors; anticarcinogenic agents for treating cancer |
| 05/14/2009 | US20090124610 Pharmaceutical compounds |
| 05/14/2009 | US20090124608 CB2 Receptor Modulators In Neurodegenerative Diseases And Applications Of The Same |
| 05/14/2009 | US20090124607 Novel Bicyclic Sulfonamides for Use as Glucocorticoid Receptor Modulators in the Treatment of Inflammatory Diseases |
| 05/14/2009 | US20090124605 Pyrazolo-Quinazoline Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors |
| 05/14/2009 | US20090124602 Kinase inhibitors |
| 05/14/2009 | US20090124039 Low temperature deposition of phase change memory materials |
| 05/14/2009 | US20090124001 9-amino-acridine derivatives and their use for eliminating misfolded proteins |
| 05/14/2009 | US20090123686 Optical recording material and cyanine compound |
| 05/14/2009 | US20090121617 Electronic devices made with electron transport and/or anti-quenching layers |
| 05/14/2009 | CA2704990A1 Processes and intermediates for producing aminobenzimidazole ureas |
| 05/14/2009 | CA2704684A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | CA2704633A1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 05/14/2009 | CA2704222A1 Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 05/14/2009 | CA2703996A1 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/14/2009 | CA2702995A1 Compounds for inhibiting ksp kinesin activity |
| 05/13/2009 | EP2058307A1 Methods for the identification of JAK kinase interacting molecules and for the purification of JAK kinases |
| 05/13/2009 | EP2058306A1 Heteroaryl-substituted 2-pyridinyl-methylamine derivatives |
| 05/13/2009 | EP2058302A1 Method for producing phenoxypyridine derivative |
| 05/13/2009 | EP2057146A1 Compounds and compositions as protein kinase inhibitors |
| 05/13/2009 | EP2057145A1 Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 05/13/2009 | EP2057144A2 Novel polymorphs of rimonabant |
| 05/13/2009 | EP2057143A2 5-substituted isoindoline compounds |